Study provides new look at why rare cancer often evades treatments
Descrição
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
Study Provides New Look at Why Rare Cancer Often Evades Treatments - Cancer Health
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Scientists reveal how proteins drive growth of multiple cancer types – Washington University School of Medicine in St. Louis
Spatial transcriptomics—the next evolution of cancer drug discovery - 10x Genomics
Rewiring cell communication to treat melanoma
Organoids study finds potential new treatment for pulmonary neuroendocrine tumors
Cancers, Free Full-Text
Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing
For a 6-year-old with cancer, a future staked on the promise of immunotherapy
Women, power, and cancer: a Lancet Commission - The Lancet
Aretha Franklin's Cancer Diagnosis Clarified - Cancer Health
de
por adulto (o preço varia de acordo com o tamanho do grupo)